NEW YORK (GenomeWeb News) – Accelerate Diagnostics today said that revenues for its first quarter rose 70 percent year over year.

The Tucson, Ariz.-based firm company, formerly called Accelr8 Technology, recorded $15,678 in revenues, compared to $9,197 a year ago. All revenues for the current and year-ago quarter came from its OptiChem business, the company said in its Form 10-Q filed with the US Securities and Exchange Commission, and the increase resulted from "fluctuations in partner sales volumes on which royalties were due the company."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.